IDEXX LABORATORIES INC /DE Accounts Payable 2009-2026 | IDXX
Beta
What is accounts payable?
Accounts payable represents money the company owes to suppliers for goods or services received but not yet paid for.
What is IDEXX LABORATORIES INC /DE's current accounts payable?
IDEXX LABORATORIES INC /DE (IDXX) annual accounts payable for 2025 was $110.4M, a 3.33% decline from 2024. IDEXX LABORATORIES INC /DE accounts payable for the quarter ending March 31, 2026 was $130.0M.
What was IDEXX LABORATORIES INC /DE's accounts payable in 2024?
IDEXX LABORATORIES INC /DE annual accounts payable for 2024 was $114.2M, a 3.22% increase from 2023.
What was IDEXX LABORATORIES INC /DE's accounts payable in 2023?
IDEXX LABORATORIES INC /DE annual accounts payable for 2023 was $110.6M, a 0.38% increase from 2022.
What is IDEXX LABORATORIES INC /DE's 5-year accounts payable CAGR?
IDEXX LABORATORIES INC /DE accounts payable grew at a compound annual growth rate (CAGR) of 8.17% from FY2020 to FY2025, going from $74.6M to $110.4M over 5 years.
Accounts Payable History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+8.2%
FY2020
$74.6M
→
FY2025
$110.4M
0910111213141516171819202122232425
5 years selected
Accounts Payable History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $110.4M | -3.3% | 10-K |
| FY2024 | $114.2M | +3.2% | 10-K |
| FY2023 | $110.6M | +0.4% | 10-K |
| FY2022 | $110.2M | -5.1% | 10-K |
| FY2021 | $116.1M | +55.8% | 10-K |
| FY2020 | $74.6M | +3.3% | 10-K |
| FY2019 | $72.2M | +3.8% | 10-K |
| FY2018 | $69.5M | +3.8% | 10-K |
| FY2017 | $67.0M | +11.5% | 10-K |
| FY2016 | $60.1M | +14.1% | 10-K |
| FY2015 | $52.6M | +17.7% | 10-K |
| FY2014 | $44.7M | +49.4% | 10-K |
| FY2013 | $29.9M | -15.2% | 10-K |
| FY2012 | $35.3M | -3.5% | 10-K |
| FY2011 | $36.6M | +61.2% | 10-K |
| FY2010 | $22.7M | +18.5% | 10-K |
| FY2009 | $19.1M | - | 10-K |
Company: IDEXX LABORATORIES INC /DETicker: IDXXSector: OtherIndustry: In Vitro & In Vivo Diagnostic SubstancesView company profile →